PEPLIN
Peplin is a development-stage specialty pharmaceutical company focused on advancing and commercializing medical dermatology products. The Company is developing PEP005 (ingenol mebutate) (PEP005), which is derived from Euphorbia peplus (E. peplus), a plant referred to as petty spurge or radium weed. Peplinโs lead product candidate, which is in Phase III clinical trials, is a patient-applied topical gel containing PEP005, a compound used for the treatment of actinic keratosis (AK). Peplin๏ฟฝ... ๏ฟฝs other product candidate is a physician-applied topical gel for the treatment of superficial basal cell carcinoma (superficial BCC), PEP005 Gel for BCC. The active compound in each product is a small molecule extracted and purified from the sap of E. peplus. On October 16, 2008, the Company acquired Neosil, Inc., a dermatology-focused company. Later on, Peplin, Inc. was acquired by LEO Pharma A/S.
PEPLIN
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
1998-01-01
Address:
Emeryville, California, United States
Country:
United States
Website Url:
http://www.peplin.com
Total Employee:
11+
Status:
Closed
Total Funding:
24 M USD
Technology used in webpage:
InterNetX DNS InterNetX
Similar Organizations
CannGoods
CannGoods is a supply chain company with a focus on building domestic and international pharmaceutical-grade regulatory pathways.
TeOra Health Ltd.
TeOra Health is a speciality pharmaceutical company focussed on the acquisition, licencing and promotion.
Current Advisors List
Investors List
GBS Ventures
GBS Ventures investment in Private Equity Round - Peplin
Orbis Investment Management
Orbis Investment Management investment in Private Equity Round - Peplin
MPM Capital
MPM Capital investment in Private Equity Round - Peplin
New Enterprise Associates
New Enterprise Associates investment in Private Equity Round - Peplin
Asia Union Investments
Asia Union Investments investment in Private Equity Round - Peplin
